Farmas USA

uso bno

ojo petroleo reunión importante, podemos estar en mínimos.

Reunión mañana 27, coincidiendo con el Día de Acción de Gracias (thanksgiving) y con el mercado USA cerrado.

Si alguién quiere hacer algo deberá esperar al viernes, pero como tienen que digerir bien el pavo, solo abierto hasta las 19h.

Hola David...
Un offering de esta noche....
Ahora quizás sí que vamos a ver tu precio...

http://ih.advfn.com/p.php?pid=nmona&article=64561691&xref=newsalert

ISCO

ONCS
http://finance.yahoo.com/news/oncs-results-newly-initiated-phase-140000517.html

Initiation of a landmark Phase II combination trial in collaboration with the UCSF and Merck to evaluate the safety, tolerability and efficacy of Merck’s anti-PD-1 drug, KEYTRUDA® (pembrolizumab) in combination with OncoSec’s ImmunoPulse therapy (intratumoral IL- 12) for the treatment of metastatic melanoma patients, who are non-responsive to KEYTRUDA®

No puede pintar mejor. Precio objetivo sube de 2$ a 4$

¿alguien que aún las mantenga como yo?

hombre Sabiopelotas! que caro eres de ver!

:)

BASF sells Norway Plant

http://www.in-pharmatechnologist.com/Ingredients/BASF-sells-Norway-plant-focuses-on-pharma-grade-omega-3-products

BASF es uno de los 4 suministradores de pastis Vascepa

AMRN

SNTA 

muy corto plazo, necesitamos un "tercer toque" para confirmar

La MM20 a puntito de cruzarse desde abajo con la MM50

Analyst Update on Short Term Price Target:Walgreen Company , Novavax Inc

http://www.marketsinsider.com/analyst-update-on-short-term-price-targetwalgreen-company-novavax-inc-2/321376/

Novavax Inc (NASDAQ:NVAX) shares are expected to touch $9.5 in the short term. This short term price target has been shared by 5 analysts. However, the standard deviation of short term price estimate has been valued at 1.41. The target price could hit $11 on the higher end and $7 on the lower end. Novavax Inc (NASDAQ:NVAX) : Optimism-led buying helped Novavax Inc (NASDAQ:NVAX)post gains of 0.19% or 0.01 points. The mood remained fairly bullish throughout the day and no significant downmove or selling pressure was witnessed. During the day, the shares fluctuated in $5.17-$5.29 but finally closed higher at $5.26. The shares had closed the previous day trading session at $5.25. The 52-week high of Novavax Inc (NASDAQ:NVAX) is at $6.95. The volume for the day was recorded at 1,984,445 shares. Currently, there are 238,478,000 outstanding shares and the company has a market cap of $1,254 million. The 52-week low of the shares is at $3.33.

Me hace gracia lo del "short-term" ... que relativo es ja,ja

NVAX

edito: añado un grafico en MENSUAL de como vamos

esos 5,60 ... que cerca y que lejillos estan ahora ...